Iso - Vet 1000 mg/g Inhalation Vapour, liquid

البلد: أيرلندا

اللغة: الإنجليزية

المصدر: HPRA (Health Products Regulatory Authority)

العنصر النشط:

Isoflurane

متاح من:

Piramal Critical Care Limited

ATC رمز:

QN01AB06

INN (الاسم الدولي):

Isoflurane

جرعة:

1000 milligram(s)/gram

الشكل الصيدلاني:

Inhalation vapour, liquid

نوع الوصفة الطبية :

VPO: Veterinary Practitioner Only as defined in relevant national legislation

المجموعة العلاجية:

Cats, Dogs, Ferrets, Gerbils, Guinea pigs, Hamsters, Horses, Other Birds, Reptiles

المجال العلاجي:

isoflurane

الخصائص العلاجية:

Neurological Preparations

الوضع إذن:

Authorised

تاريخ الترخيص:

2011-11-25

خصائص المنتج

Health Products Regulatory Authority
02 January 2019
CRN000YZN
Page 1 of 12
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Iso - Vet 1000 mg/g Inhalation Vapour, liquid
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Substance:
Isoflurane 1000 mg/g
The veterinary medicinal product contains no excipients.
3 PHARMACEUTICAL FORM
Inhalation vapour, liquid.
Clear, colourless, mobile, heavy liquid.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Horses, dogs, cats, ornamental birds, reptiles, rats, mice, hamsters,
chinchillas, gerbils,
guinea pigs and ferrets.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Induction and maintenance of general anaesthesia.
4.3 CONTRAINDICATIONS
Do not use in cases of known susceptibility to malignant hyperthermia.
Do not use in cases of known hypersensitivity to isoflurane.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
The ease and rapidity of alteration of the depth of anaesthesia with
isoflurane and its
low metabolism, may be considered advantageous for its use in special
groups of
patients such as the old or young, and those with impaired hepatic,
renal or cardiac
function.
Health Products Regulatory Authority
02 January 2019
CRN000YZN
Page 2 of 12
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Isoflurane has little or no analgesic properties. Adequate analgesia
should always be
given before surgery. The analgesic requirements of the patient should
be
considered before general anaesthesia is ended.
The use of the product in patients with cardiac disease should be
considered only
after a risk/ benefit assessment by the veterinarian.
It is important to monitor breathing and pulse for the frequency and
its features.
Respiratory arrest should be treated by assisted ventilation. It is
important to
maintain airways free and properly oxygenate tissues during the
maintenance of
anaesthesia. In the case of cardiac arrest, perform a complete cardio
pulmonary
resuscitation.
The metabolism of isoflurane in birds and small mammals, can be